… However, our results contrast with the results from previous meta-analyses that analyzed
the all-cause mortality risk after inhaled therapy containing ICSs in patients with COPD.75, 76, …

… This systematic review and meta-analysis explored the association of the risk of pneumonia
in COPD patients that were undergoing treatment using ICS alone or together with LABAs or …

… the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper respiratory
tract infection (URTI) with long-term inhaled corticosteroid use among patients with asthma. …

… Inhaled corticosteroids (ICS) are the treatment of choice for long-term asthma control in both
… Therefore, the aim of this study was to perform a meta-analysis of RCTs to assess the safety …

… an increased risk of progressive lung function impairments and fixed airflow obstruction,
there is ongoing debate on whether inhaled corticosteroids (ICS) modify these long-term risks. …

… A meta-analysis was implemented to evaluate whether exposure to inhaled corticosteroids
was associated with risk of pneumonia. We used Review Manager 5.3 software (v.5.3, …

… The search strategy was as follows: asthma AND (“inhaled corticosteroid” OR “inhaled
steroid” OR beclomethasone OR budesonide OR ciclesonide OR flunisolide OR fluticasone OR …

… The meta-analysis performed here was undertaken here to address the hypothesis that ICS
… the risk of URTI in patients with COPD. This meta-analysis revealed that the increased risk of …

… High doses of inhaled corticosteroids (ICS) reduce the risk of hospital admission in patients
with acute asthma presenting to emergency department (ED). However, the evidence so far …

… Trial descriptions and meta-analysis results Our results support the use of inhaled
corticosteroids (ciclesonide or budesonide) for the resolution of symptoms at day 14 of treatment. …